Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo E Mendes

Showing results (161-170 of 257) with videos related to

Pageof 26
Sort By:
The Journal of Antimicrobial Chemotherapy|December 4, 2020
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Helio S Sader, Cecilia G Carvalhaes, S J Ryan Arends, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2022
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 14, 2018
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin AmericaHelio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Journal of Global Antimicrobial Resistance|August 5, 2022
The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel β-lactam/β-lactamase inhibitor combinationsMariana Castanheira, Timothy B Doyle, Cory M Hubler, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance ProgramHelio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2022
<i>In Vitro</i> Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020)Rodrigo E Mendes, Cory Hubler, J H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilliRodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae IsolatesHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 28, 2013
Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineagesMariana Castanheira, Sarah E Farrell, Audrey Wanger, et al.
Pageof 26

Showing results (161-170 of 257) with videos related to

Sort By:
Pageof 26
The Journal of Antimicrobial Chemotherapy|December 4, 2020
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019Helio S Sader, Cecilia G Carvalhaes, S J Ryan Arends, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2022
Antimicrobial activities of aztreonam-avibactam and comparator agents tested against Enterobacterales from European hospitals analysed by geographic region and infection type (2019-2020)Helio S Sader, Rodrigo E Mendes, S J Ryan Arends, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 14, 2018
Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin AmericaHelio S Sader, Robert K Flamm, Jennifer M Streit, et al.
Journal of Global Antimicrobial Resistance|August 5, 2022
The plethora of resistance mechanisms in Pseudomonas aeruginosa: transcriptome analysis reveals a potential role of lipopolysaccharide pathway proteins to novel β-lactam/β-lactamase inhibitor combinationsMariana Castanheira, Timothy B Doyle, Cory M Hubler, et al.
International Journal of Antimicrobial Agents|December 29, 2004
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance ProgramHelio S Sader, Mariana Castanheira, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy|September 28, 2022
<i>In Vitro</i> Activity of Tebipenem against Various Resistant Subsets of Escherichia coli Causing Urinary Tract Infections in the United States (2018 to 2020)Rodrigo E Mendes, Cory Hubler, J H Kimbrough, et al.
Antimicrobial Agents and Chemotherapy|March 20, 2013
Potency and spectrum of activity of AN3365, a novel boron-containing protein synthesis inhibitor, tested against clinical isolates of Enterobacteriaceae and nonfermentative Gram-negative bacilliRodrigo E Mendes, M R K Alley, Helio S Sader, et al.
Antimicrobial Agents and Chemotherapy|October 25, 2017
Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae IsolatesHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
Open Forum Infectious Diseases|March 22, 2019
Antimicrobial Susceptibility of <i>Streptococcus pneumoniae</i> from North America, Europe, Latin America, and the Asia-Pacific Region: Results From 20 Years of the SENTRY Antimicrobial Surveillance Program (1997-2016)Helio S Sader, Rodrigo E Mendes, Jennifer Le, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 28, 2013
Rapid expansion of KPC-2-producing Klebsiella pneumoniae isolates in two Texas hospitals due to clonal spread of ST258 and ST307 lineagesMariana Castanheira, Sarah E Farrell, Audrey Wanger, et al.
Pageof 26